Ethyl Alcohol 95% (5ML vial) Injectable, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.
Pharmacy Innovations
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
💊
Drugs Recalls
Prescription and over-the-counter medications
17,302 Total Recalls
LIDOCAINE-PF- 5% (5ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.
Pharmacy Innovations
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
DEXAMETHASONE 16MG/ML (3ML VIAL) INJECTABLE; DEXAMETHASONE 24MG/ML INJECTABLE; DEXAMETHASONE-PF- 0.1% (1ML DROPPER) OPH SOLUTION, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.
Pharmacy Innovations
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
PHOSPHATIDYLCHOLINE/DEOXYCHOLIC ACID (10ML VIAL) 50MG/50MG/ML (5%/5%) INJECTABLE; Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.
Pharmacy Innovations
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Class I - Dangerous
Short Fill
GLYCERIN STERILE 99% 2ML VIAL and 5ML VIAL, Injectable, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.
Pharmacy Innovations
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Class I - Dangerous
CGMP Deviations: Voluntary recall of all hand sanitizer distributed after March 31, 2022, due to FDA issued guidance to cease placing hand sanitizer product, produced under temporary approval, into the market after March 31, 2022.
Class I - Dangerous
CGMP Deviations:
Class I - Dangerous
CGMP Deviations:
Class I - Dangerous
CGMP Deviations:
Class I - Dangerous
Labeling mixup: cartons labeled as Daptomycin 350 mg/vial were found to contain vials of Daptomycin 500 mg per vial
Class I - Dangerous
CGMP Deviations:
Class I - Dangerous
CGMP Deviations:
Class I - Dangerous
CGMP Deviations and Superpotent Drug: Levels of acetal and acetaldehyde above allowable limits. Additionally, lot 001 was superpotent.
CGMP Deviations:
Class I - Dangerous
Subpotent Drug: Testing results below the defined limit for the epinephrine portion of this product.
Class I - Dangerous
CGMP Deviations: Voluntary recall of all hand sanitizer distributed after March 31, 2022, due to FDA issued guidance to cease placing hand sanitizer product, produced under temporary approval, into the market after March 31, 2022.
Class I - Dangerous
CGMP Deviations:
Class I - Dangerous
Failed Impurity/Degradation Specifications
Class I - Dangerous
CGMP Deviations: